Results 71 to 80 of about 14,618 (167)

Optimizing rabies mRNA vaccine efficacy via RABV-G structural domain screening and heterologous prime-boost immunization

open access: yesnpj Vaccines
mRNA vaccine has become a promising technology platform for rabies prevention. This study explores the roles of different structural domains of rabies virus glycoprotein (RABV-G) and heterologous prime-boost strategies for enhanced immune responses and ...
Dongdong Li   +11 more
doaj   +1 more source

Background paper for developing a policy for the use of rabies biologicals and vaccination of humans in India

open access: yesIndian Journal of Public Health, 2019
National Rabies Control Programme, India, is in operation since 2012–2013 without much impact due to poor funding and no set policy for the rabies prevention and control. An effort was made to develop a draft policy paper which can help the Government of
Mysore Kalappa Sudarshan   +1 more
doaj   +1 more source

A Novel, Safe, Non-Adjuvanted Alphavirus RNA Particle Vaccine Expressing the Rabies Virus Glycoprotein Induces a Three-Year Duration of Immunity in Dogs and Cats After a Single Vaccine Dose

open access: yesVaccines
Background/Objectives: To this day, rabies remains a significant global threat. This threat remains even with the availability of vaccines for humans, wildlife, and domestic animals, which are used as part of a series of interventions to attempt to ...
Ken Stachura   +5 more
doaj   +1 more source

Reconciling the Use of Human Fetal Tissue in Research

open access: yes
Annals of the Child Neurology Society, Volume 4, Issue 2, Page 112-114, June 2026.
Harvey B. Sarnat   +4 more
wiley   +1 more source

The unsung virtue of thermostable anti-rabies vaccine

open access: yesOpen Veterinary Journal
Vaccination is the most effective tool to protect against rabies. Currently, two different types of vaccines, i.e., tissue culture and cell culture vaccines, are available for prophylaxis against rabies in both animals and humans.
Krishna Prasad Acharya, Sarita Phuyal
doaj   +1 more source

RABIES IN UKRAINE: EPIDEMIOLOGICAL AND EPIZOOTIC SITUATION, MEANS FOR PREVENTIVE AND THERAPEUTIC IMMUNIZATION [PDF]

open access: yesAnnals of Mechnikov's Institute, 2013
Epidemiological and epizootic situations of rabies in Ukraine were analyzed. Active centers of animal rabies formed in many areas where 2016 persons were attacked by animals (mostly dogs suspected on rabies) during 2011 year.
Lavrik A.,, Novikova O.,, Panchenko L.
doaj  

Unusual reaction to rabies vaccine

open access: yesCommunicable Diseases Intelligence, 2002
This report describes a previously undescribed reaction to human diploid cell rabies vaccine (HDCV). The vaccine is available for prophylaxis against Australian bat lyssavirus (ABL) infection both prior to and after possible exposure. Australian bat lyssavirus is the most recent lyssavirus to be discovered and has been linked to at least one death in ...
Maussen, Jules W   +2 more
openaire   +3 more sources

Documenting challenges in achieving rabies elimination by 2030 in low-middle income countries; a Kenyan case study from Lamu County, 2020–2022: mixed methods approach

open access: yesOne Health Outlook
Background Kenya launched a Rabies Elimination Strategy in 2014, aiming to end human rabies deaths by 2030. In March 2022, Lamu County reported increased cases of human dog bites and suspected rabies deaths to the Ministry of Health (MoH).
Nassoro Mwanyalu   +8 more
doaj   +1 more source

Long-term immunity induced by SPBN GASGAS in orally vaccinated dogs is non-inferior to inactivated rabies vaccines. [PDF]

open access: yesVaccine X, 2023
Vos A   +9 more
europepmc   +1 more source

Bacillus subtilis vector based oral rabies vaccines induced potent immune response and protective efficacy in mice. [PDF]

open access: yesFront Microbiol, 2023
Zhang Y   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy